Contact
Please use this form to send email to PR contact of this press release:
Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy
TO:
Please use this form to send email to PR contact of this press release:
Apellis Provides 24-Month Update from Phase 1b Study of Pegcetacoplan in Patients with Geographic Atrophy
TO: